Skip to Content

Influenza A (H1N1) 2009 Monovalent Vaccine Approval History

  • FDA approved: Yes (First approved September 15th, 2009)
  • Brand name: Influenza A (H1N1) 2009 Monovalent Vaccine
  • Generic name: H1N1 influenza virus vaccine
  • Company: CSL Limited; Novartis Vaccines and Diagnostics Limited; Sanofi Pasteur, Inc.; MedImmune LLC
  • Treatment for: Influenza Prophylaxis

Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 6 months of age and older against influenza disease caused by pandemic (H1N1) 2009 virus.

Development History and FDA Approval Process for Influenza A (H1N1) 2009 Monovalent Vaccine

Nov 13, 2009Approval FDA Expands Approved Use of H1N1 Vaccines to Include Infants and Children
Sep 16, 2009Approval FDA Approves Vaccines for 2009 H1N1 Influenza Virus

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.